HbA1c and blood sugar: normal values, diagnostic cutoffs, and targets
\n
HbA1c reflects average blood glucose over roughly the past two to three months. Under 42 mmol/mol (about 6.0%) is usually normal; 42–47 mmol/mol suggests prediabetes; 48 mmol/mol (about 6.5%) or higher is at diabetes level. Fasting capillary glucose under 6.0 mmol/L (about 108 mg/dL) is typically normal. Diagnostic thresholds are not the same as individualized treatment goals.
Normal values and cutoffs — tables first
These are the numbers most people look up: what counts as normal, what suggests prediabetes, and what sits at diabetes level. Diagnosis cutoffs and treatment targets are not the same — more on that below.
HbA1c: normal, prediabetes, diabetes
In many countries (including Sweden), mmol/mol is the primary unit; percent (%) is still widely used internationally (NGSP/%).
| Interpretation | HbA1c |
|---|---|
| Normal (no diabetes diagnosis) | under 42 mmol/mol (under ≈ 6.0%) |
| Prediabetes | 42–47 mmol/mol (≈ 6.0–6.4%) |
| Diabetes-level | 48 mmol/mol or higher (≈ 6.5%) |
Important: These thresholds are used mainly for diagnosis. If you already have diabetes, your personal target is set with your care team — based on age, treatment, other conditions, and risk of low blood sugar (hypoglycemia).
Fasting glucose and OGTT (capillary vs venous)
A fingerstick gives a capillary reading. Clinics often draw blood from an arm vein (venous). Cutoffs differ slightly by sample type. Fasting usually means at least 8 hours without food.
Approximate normal glucose ranges (guidance only):
| Sample type | Approximate normal range |
|---|---|
| Capillary | 4.4–6.0 mmol/L (≈ 79–108 mg/dL) |
| Arterial | 4.4–5.6 mmol/L (≈ 79–101 mg/dL) |
| Venous | 3.9–5.5 mmol/L (≈ 70–99 mg/dL) |
Capillary fasting glucose under 6.0 mmol/L is usually considered normal. Values around 6.1–6.9 mmol/L fasting may indicate impaired fasting glucose / a prediabetes range and should be interpreted in clinical care — not from a single home reading alone.
Diagnostic plasma glucose cutoffs (mmol/L) — aligned with common European practice and Diabetes Manualen criteria:
| Venous | Capillary | |
|---|---|---|
| Diabetes — fasting | ≥ 7.0 | ≥ 7.0 |
| Diabetes — 2 h after OGTT | ≥ 11.1 | ≥ 12.2 |
| Impaired glucose tolerance — fasting | < 7.0 | < 7.0 |
| Impaired glucose tolerance — 2 h after OGTT | ≥ 7.8 and < 11.1 | ≥ 8.9 and < 12.2 |
Approximate mg/dL equivalents for the diabetes fasting and 2-hour venous cutoffs: ≥ 126 mg/dL fasting and ≥ 200 mg/dL at 2 hours after a 75 g glucose load.
A random (non-fasting) plasma glucose > 11.1 mmol/L (> 200 mg/dL) can also support a diabetes diagnosis, especially with classic symptoms. An oral glucose tolerance test (OGTT) uses 75 g glucose after fasting, with measurements before and at two hours.
How diagnosis is made
When one value is enough — and when repeat testing is needed
Usually two elevated results (same or different methods) are needed before diabetes is diagnosed — unless clear symptoms accompany a very high random value. Treat a single home meter reading cautiously. Persistent or unexplained symptoms are still a reason to have glucose and HbA1c assessed in care; see also diabetes symptoms.
When HbA1c can mislead
HbA1c reflects how much hemoglobin is glycated. Conditions that alter red blood cells — certain anemias, hemoglobinopathies, major bleeding or transfusion, pregnancy, or advanced kidney disease — can make HbA1c less reliable. In those settings, glucose tests and the clinical picture matter more.
Treatment targets when you already have diabetes
The diagnostic threshold (≥ 48 mmol/mol / ≈ 6.5%) is not automatically your personal treatment goal.
Individualized goals (age, hypoglycemia risk, comorbidities)
Goals are set with you: age, other illnesses, whether you use insulin, tablets, or mainly lifestyle, and how high the risk of hypoglycemia is.
Lower HbA1c generally lowers risk of microvascular complications (eyes, kidneys, nerves), but overly aggressive lowering can increase hypoglycemia — especially in type 1 diabetes and with intensive insulin therapy. Guidelines from ADA, EASD, and national societies emphasize individualization. Many people aim toward the low-50s mmol/mol range when safe; others need less stringent targets.
As a clinical orientation from existing Diabetes.nu / Manualen material: HbA1c under 48 mmol/mol (rough average glucose around 7.8 mmol/L / ≈ 140 mg/dL, with fasting often in the 6–8 mmol/L range and daytime values often under 10 mmol/L when safe to achieve) is sometimes framed as a tighter “optimal” band — not a DIY target.
Why lower is not always better
Lower is not always better for you. With high hypoglycemia risk, frailty, limited life expectancy, or impaired warning symptoms, a somewhat higher target can be safer. That decision belongs with your diabetes team — not as self-adjustment of insulin or tablets.
Why HbA1c and glucose matter for complications
Following glucose and HbA1c helps reduce acute problems (hypoglycemia and hyperglycemia) and longer-term complications such as retinopathy, nephropathy, neuropathy, and cardiovascular disease.
Complication risk generally rises when HbA1c stays higher over time. That does not mean every person at a given value gets the same damage — or that one lab result “decides” the future. Eye disease has been described near diagnostic-range HbA1c in some people with type 1 diabetes; that supports good control, but it is not a hard personal cutoff that replaces clinical judgment.
Swedish registry research has linked higher (out-of-target) HbA1c to higher cardiovascular risk in type 2 diabetes, while blood pressure, lipids, smoking, and kidney function also matter (Rawshani A et al., N Engl J Med 2018). Meeting an HbA1c goal does not erase all residual risk, especially for heart failure.
How blood sugar and HbA1c are measured
Fingerstick (self-monitoring)
With a glucose meter, test strip, and lancet, you obtain a drop of blood — usually from a fingertip. Wash and dry hands, use a new lancet, and never share equipment. Alternate sites may hurt less but are less reliable when glucose is changing fast (right after meals, after insulin, or after exercise). Then fingertip is safer.
Continuous glucose monitoring (CGM)
CGM uses a small sensor to measure glucose in interstitial fluid under the skin. That signal tracks blood glucose closely enough to guide treatment for many people. CGM does not always replace fingersticks (calibration, suspected sensor error, certain situations), but it often cuts how often you need to prick.
Laboratory HbA1c
HbA1c is a venous (or clinic) blood test reflecting roughly the past 2–3 months. Recent weeks weigh most. Unlike a fingerstick, it is not swayed by what you ate an hour ago.
How often to check
HbA1c is often checked every three to six months, more often if treatment changes or values swing widely. Daily glucose checks depend on diabetes type, medicines, and goals.
Type 1 diabetes
Frequent monitoring is needed to dose insulin safely and avoid highs and lows. Many people check at least four times daily with fingersticks if they do not use CGM; pumps, multiple daily injections, or pregnancy can require more. CGM and modern insulin regimens are common tools.
Type 2 diabetes
In type 2 diabetes, check frequency follows treatment. Fingersticks are especially useful on insulin or other drugs that can cause hypoglycemia, or when you and your team are adjusting therapy. If you manage mainly with diet and medicines without hypoglycemia risk, daily home checks are often less necessary — but clinic HbA1c follow-up still matters.
Regular checks help you understand symptoms and adjust lifestyle and treatment with your team. Frequent fingersticks alone do not automatically extend life for everyone with type 2 diabetes.
Type- and age-specific notes
Type 2: HbA1c over time
Early after diagnosis, many people still produce insulin, so glucose can be easier to control. Over years, beta-cell function may decline and HbA1c can rise unless treatment is adapted. Swedish National Diabetes Register data illustrate this pattern over the first decade after diagnosis (Rawshani A [Araz] et al., BMJ Open 2015 — first author Araz Rawshani).
Lifestyle changes — more activity and dietary patterns such as Mediterranean-style eating or, for some, lower-carbohydrate approaches — can improve glucose markedly, especially early. Metformin has strong evidence and rarely causes hypoglycemia when used as intended. Many newly diagnosed people should agree a clear HbA1c and glucose goal with care — and not stop metformin on their own just because values temporarily look good.
Substantial weight loss can, in some cases, lead to remission — normalized values without diabetes medicines for a period — especially with shorter disease duration. Remission is not a guaranteed permanent cure; relapse occurs. Discuss realistic goals with your clinician.
Type 1: insulin, CGM, pumps
In type 1 diabetes there is little or no own insulin production. Treatment depends on insulin, often with CGM and sometimes a pump. Control is harder than in many type 2 cases, but also more data-driven. Registry work shows that the more risk factors (including HbA1c) sit in target, the lower average risk of death and cardiovascular events in type 1 — without risk falling to zero (Rawshani A et al., Circulation 2017).
Older or severely ill adults — gentler goals, not “anything goes”
In older or severely ill people, chasing the same strict goals as in younger, otherwise healthy adults is often unrealistic and sometimes harmful. Care teams may choose gentler HbA1c and glucose targets to reduce hypoglycemia and treatment burden.
That does not mean arbitrarily high values are fine as a self-made rule. Very high glucose can cause thirst, frequent urination, fatigue, and other symptoms; prolonged severe hyperglycemia is not harmless. Any higher accepted range is set individually by the care team.
Low blood sugar (hypoglycemia) — brief practical note
Low glucose often starts around 3.0–3.5 mmol/L (≈ 54–63 mg/dL) or lower, though symptoms can appear earlier or later. Early signs may include shaking, sweating, hunger, palpitations, irritability, and headache. Severe episodes can cause confusion, seizures, or loss of consciousness. Some people with long-standing diabetes lose warning symptoms.
A common first step when the person is conscious is about 15 g of fast-acting carbohydrate, then recheck in about 15 minutes — following the plan your clinic gave you. Impaired consciousness needs help from others / emergency care. See hypoglycemia.
In type 1 diabetes, with high glucose (roughly 14–17 mmol/L / ≈ 250–300 mg/dL), illness, or symptoms such as nausea and abdominal pain, ketone checking may be needed. High ketones can lead to diabetic ketoacidosis (DKA) — contact care per your sick-day instructions.
What HbA1c actually measures
HbA1c is the share of hemoglobin in red blood cells that has glucose attached. Higher average glucose → higher HbA1c. That is why the test works as a multi-month “average,” complemented — not replaced — by fingersticks and CGM in daily life.
Sources
- Diabetes Manualen / Diabeteshandboken — diagnostic criteria and clinical orientation (diabetes.nu)
- ADA Standards of Care in Diabetes (general framing: individualized glycemic goals; dual reporting of HbA1c units)
- EASD / ADA consensus statements on type 2 diabetes management (individualized targets; hypoglycemia awareness)
- Rawshani A (Araz) et al. Impact of ethnicity on progress of glycaemic control in newly diagnosed type 2 diabetes. BMJ Open 2015;5:e007599
- Rawshani A, Rawshani A, et al. Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med 2018;379:633–644
- Rawshani A, Rawshani A, et al. Range of Risk Factor Levels… Type 1 Diabetes. Circulation 2017;135:1522–1531